| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8aa526ab8413daf73be707d2d370b9e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bb09a736c428fe98849553ac976053a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23bb25e15808e661477f30f83d1330a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b99c3b88a6fe323b9b01ddabca696c2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf5338ea657224fd87d9f185edf77d60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e8d2ad0d323ea6537a21fca45702167 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
| filingDate |
2009-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e14b9313b09d59bba510bf7aa7fb8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f381f601485d18a794f22d42a8748a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b486dfa9d5bfcafd993f6b9e4cb4f04d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65f41f42a7e3c694288fbdae41cd0d90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0125aeaeefc9f5c576e1029732b491ae |
| publicationDate |
2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009116061-A2 |
| titleOfInvention |
Stable oral pharmaceutical composition comprising atorvastatin |
| abstract |
The present invention relates to a stable oral pharmaceutical composition comprising atorvastatin or its pharmaceutically acceptable salt and alkaline aluminium salts in an amount sufficient to prevent degradation of the atorvastatin or its pharmaceutically acceptable salt. |
| priorityDate |
2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |